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Abstract
Aims: To define the mechanisms underlying pyrazole-induced oxidative stress and the protective role of per-
oxiredoxins (Prxs) and sulfiredoxin (Srx) against such stress. Results: Pyrazole increased Srx expression in the
liver of mice in a nuclear factor erythroid 2–related factor 2 (Nrf2)-dependent manner and induced Srx trans-
location from the cytosol to the endoplasmic reticulum (ER) and mitochondria. Pyrazole also induced the
expression of CYP2E1, a primary reactive oxygen species (ROS) source for ethanol-induced liver injury, in ER
and mitochondria. However, increased CYP2E1 levels only partially accounted for the pyrazole-mediated in-
duction of Srx, prompting the investigation of CYP2E1-independent ROS generation downstream of pyrazole.
Indeed, pyrazole increased ER stress, which is known to elevate mitochondrial ROS. In addition, pyrazole up-
regulated CYP2E1 to a greater extent in mitochondria than in ER. Accordingly, among Prxs I to IV, PrxIII, which
is localized to mitochondria, was preferentially hyperoxidized in the liver of pyrazole-treated mice. Pyrazole-
induced oxidative damage to the liver was greater in PrxIII -/ - mice than in wild-type mice. Such damage was
also increased in Srx -/ - mice treated with pyrazole, underscoring the role of Srx as the guardian of PrxIII.
Innovation: The roles of Prxs, Srx, and ER stress have not been previously studied in relation to pyrazole
toxicity. Conclusion: The concerted action of PrxIII and Srx is important for protection against pyrazole-induced
oxidative stress arising from the convergent induction of CYP2E1-derived and ER stress-derived ROS in mi-
tochondria. Antioxid. Redox Signal. 17, 1351–1361.
Introduction
The hepatotoxin pyrazole is a substrate of cytochromeP450 2E1 (CYP2E1). Similar to many other substrates for
CYP2E1, pyrazole increases the expression of this enzyme at
the level of protein stabilization (32). Such up-regulation of
CYP2E1 results in oxidative stress, because electron transfer
from the donor system to CYP2E1 is not perfectly coupled
and is, therefore, leaky (27, 30), and the leaked electrons
react with O2 to produce reactive oxygen species (ROS).
CYP2E1 is a major ROS producer that plays a central role in
the pathogenesis of alcoholic liver injury (17, 20). Pyrazole
has been widely used as an inducer of CYP2E1 in studies of
CYP2E1-dependent oxidative stress and liver injury (21, 38,
39). Although CYP2E1 is predominantly localized to the
endoplasmic reticulum (ER) (19), it is also present in mito-
chondria of the liver (1, 4, 24, 29). Pyrazole increases the
abundance of CYP2E1 in both the ER and mitochondria of
the rat liver (4, 29, 35).
Peroxiredoxins (Prxs) catalyze the reduction of ROS, with a
catalytic cysteine (Cys) residue serving as the site of oxidation
Innovation
Pyrazole has been widely used as an inducer of CYP2E1
in studies of CYP2E1-dependent oxidative stress and liver
injury. 2-cysteine peroxiredoxins (Prxs) (PrxI to IV) inevi-
tably undergo hyperoxidation during the elimination of
reactive oxygen species (ROS). Taking advantage of the fact
that Prx isoforms reside in different subcellular compart-
ments, the extent of hyperoxidation of each Prx isoformwas
measured to define the localization of ROS production.
Here, we found that PrxIII, which is specifically localized to
mitochondria, was preferentially hyperoxidized in the liver
in response to exposure to pyrazole. This is likely because
pyrazole increases CYP2E1 abundance to a greater extent in
mitochondria than in the endoplasmic reticulum (ER) and
because it induces ER stress that results in increased Ca2+
and ROS levels in mitochondria. Using mice lacking either
PrxIII or sulfiredoxin, the pivotal function of the two en-
zymes inmitigating hepatotoxicity in pyrazole-treatedmice
was demonstrated.
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by peroxides (28). The six mammalian Prx isoforms (PrxI to
VI) show distinct subcellular distributions (12, 18, 28, 34). PrxI
is located in the cytosol, in the plasma membrane, and at the
cytosolic side of the ER membrane; PrxII and PrxVI are pre-
dominantly localized in the cytosol; PrxIV is restricted to the
ER lumen; PrxV is present in the cytosol, mitochondria, and
peroxisomes; and PrxIII is synthesized with a mitochondrial
targeting sequence and is exclusively localized in the mito-
chondria. PrxI to PrxIV, the four members of the 2-Cys Prx
subgroup, exist as homodimers and possess two conserved
Cys residues. In the catalytic cycle of 2-Cys Prxs, peroxides
oxidize the sulfhydryl group of the NH2-terminal conserved
Cys (designated the peroxidatic Cys, or CP–SH) to Cys sul-
fenic acid (Cys–SOH), which then reacts with the COOH-
terminal conserved Cys–SH (the resolving Cys, CR–SH) of the
other subunit in the homodimer to form a disulfide. The re-
sulting disulfide is subsequently reduced by thioredoxin to
complete the catalytic cycle. As a result of the slow rate of its
reaction with CR–SH, CP–SOH is occasionally further oxi-
dized to Cys sulfinic acid (Cys–SO2H) (26, 40). This hyper-
oxidation reaction, which results in the inactivation of
peroxidase function, is reversed by the ATP-dependent en-
zyme sulfiredoxin (Srx) (6,36,37).
We previously showed that chronic ethanol consumption
in mice results in the hyperoxidation of PrxI, but not that of
the other 2-Cys Prxs, in the liver (2). This specific inactivation
of PrxI was due to the colocalization of a large proportion of
PrxI molecules with CYP2E1 at the cytosolic side of the ER
membrane. We now show that pyrazole induces hyperox-
idation of the mitochondrial enzyme PrxIII, but not that of
PrxI, in mouse liver, suggesting that ROS are predominantly
produced by mitochondria in the liver of pyrazole-injected
mice. The pronounced oxidative damage induced by pyrazole
inmice lacking either Srx or PrxIII indicated that the concerted
action of these enzymes is important for protection against the
pyrazole-induced oxidative stress.
Results
Pyrazole upregulates Srx protein and mRNA in mouse
liver via an Nrf2-dependent pathway
An intraperitoneal injection of mice with pyrazole at doses
of 75, 150, or 300mg/kg resulted in a marked increase in the
amount of Srx protein in the liver measured 18 h later by
immunoblot analysis, with this effect being maximal at the
dose of 150mg/kg (Supplementary Fig. S1; Supplementary
Data are available online at www.liebertonline.com/ars). The
abundance of Srx protein in the liver was increased*17-fold
by an injection of pyrazole at 150mg/kg (Fig. 1A, B). Reverse
transcription (RT) and real-time polymerase chain reaction
(PCR) analysis also showed that pyrazole induced an *22-
fold increase in the amount of Srx mRNA in the liver (Fig. 1C).
An immunohistochemical analysis revealed that Srx was lo-
calized around the central vein of the liver in pyrazole-
injected mice (Fig. 1D). Immunoreactivity was detected in the
cytoplasm and the nucleus (Fig. 1D), and the presence of a
small fraction of Srx in the nucleus was confirmed by im-
munoblot analysis after subcellular fractionation (Fig. 1E).
Transcription of the Srx gene is regulated through a cis-
acting element antioxidant-responsive element (ARE) that is
activated by the binding of nuclear factor erythroid 2–related
factor 2 (Nrf2) or activator protein-1 (AP-1). We previously
showed that induction of Srx in the mouse liver in response to
ethanol feeding is predominantly mediated via an Nrf2
pathway (2). We, therefore, examined whether the same
pathway mediates the pyrazole-induced expression of Srx
with the use of Nrf2 knockout (Nrf2 -/ - ) mice (Supplemen-
tary Fig. S2A). The pyrazole-induced expression of Srx at both
protein (Fig. 2A, B) and mRNA (Supplementary Fig. S2B)
levels was greatly attenuated in Nrf2 -/ - mice comparedwith
that in wild-type animals, suggesting that Nrf2 plays a key
role in this process. However, the fact that pyrazole-induced
Srx expression was not totally abolished in the liver of
Nrf2 -/- mice suggested that other transcription factors such
FIG. 1. Induction of sulfiredoxin (Srx) expression in the
liver of mice treated with pyrazole (Pyr). (A) The liver of mice
intraperitoneally injected with saline (- ) or Pyr (150mg/kg)
was isolated 18h after the injection, and liver homogenates
(20lg of protein) were subjected to an immunoblot analysis
with antibodies to Srx or to b-actin (loading control). Data are
representative of three independent experiments. (B) Densito-
metric analysis of Srx protein expression for the immunoblots
similar to those in (A). Data were normalized by the amount of
b-actin and then expressed relative to the corresponding mean
value for saline-injected mice. Data are mean– standard devi-
ation (SD). *p<0.01 versus the saline group. (C) Total RNA
prepared from the liver tissue of mice treated as in (A) was
subjected to reverse transcription (RT) and real-time polymer-
ase chain reaction (PCR) analysis for determination of the
amounts of Srx mRNA. Data were normalized by the amount
of 18S rRNA and then expressed relative to the corresponding
value for saline-injected mice. Data are mean–SD. **p<0.02
versus the saline group. (D) Liver sections from mice treated as
in (A)were subjected to an immunohistochemical analysis with
or without antibodies (Ab- ) to Srx with the use of an ABC
staining kit (Vector Laboratories, Mississauga, Ontario, Cana-
da). CV, central vein. Original magnification, 100· . (E) The
cytosolic and nuclear fractions (20lg of protein) prepared from
the liver tissue of mice treated as in (A) were subjected to an
immunoblot analysis with antibodies to Srx, to lamin B, or to
tubulin. Data are representative of three independent experi-
ments. (To see this illustration in color the reader is referred to
the web version of this article at www.liebertpub.com/ars.)
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FIG. 2. Role of nuclear factor erythroid 2–related factor 2 (Nrf2) and CYP2E1 in pyrazole-induced Srx expression in the
liver. (A) Homogenates (20 lg of protein) of the liver prepared from Nrf2 +/ + or Nrf2 -/- mice 18 h after an intraperitoneal
injection with saline ( - ) or pyrazole (150mg/kg) were subjected to an immunoblot analysis with antibodies specific for either
Srx or b-actin. Data are representative of three independent experiments. (B) Densitometric analysis of relative Srx abundance
in immunoblots similar to those in (A). Data are means – SD. *p< 0.01 versus wild-type mice injected with pyrazole. (C)Wild-
type mice were intraperitoneally injected first with chlormethiazole (CMZ, 50mg/kg) or saline ( - ) and then 18 h later, with
saline (- ) or pyrazole (150mg/kg). Liver homogenates (20lg of protein) prepared 18 h after the second injection were
subjected to an immunoblot analysis with antibodies to CYP2E1, to Srx, or to b-actin. Data are representative of three
independent experiments. (D, E) Densitometric analysis of relative CYP2E1 (D) and Srx (E) abundance in immunoblots
similar to those in (C). Data are means – SD. **p < 0.05 versus corresponding mice injected with pyrazole without the treat-
ment of CMZ. (F) Wild-type mice were intraperitoneally injected with or without NAC (150mg/kg) before the pyrazole
injection (150mg/kg). Liver homogenates (20 lg of protein) prepared 18 h after the pyrazole injection were subjected to an
immunoblot analysis with antibodies specific for either Srx or b-actin. Data are representative of three independent exper-
iments. (G) Densitometric analysis of Srx protein expression for the immunoblots similar to those in (F). Data were nor-
malized by the amount of b-actin and then expressed relative to the corresponding mean value for saline-injected mice. Data
are mean– SD. *p < 0.03 versus the corresponding mice injected with pyrazole without treatment of NAC. (H) Total RNA
prepared from the liver tissue of mice treated as in (F) was subjected to RT and real-time PCR analysis for the determination
of the amounts of Srx mRNA. Data were normalized by the amount of 18S rRNA and then expressed relative to the
corresponding value for saline-injected mice. Data are mean – SD. **p< 0.05 versus the corresponding mice injected with
pyrazole without the treatment of NAC.
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as AP-1 may contribute to the transcriptional activation of the
Srx gene by pyrazole.
To determine whether the induction of Srx expression by
pyrazole depends on CYP2E1 induction, we examined the ef-
fect of an earlier injection of mice with chlormethiazole, which
inhibits CYP2E1 expression. Chlormethiazole attenuated the
pyrazole-induced increase in the amount ofCYP2E1 in the liver
by *90% (Fig. 2C, D), whereas it inhibited the pyrazole-
induced up-regulation of Srx by*40% (Fig. 2C, E). These re-
sults suggested that oxidative stress resulting from increased
CYP2E1 expression is responsible, in part, for the induction of
Srx expression by pyrazole. The role of oxidative stress is
supported by the fact that a preinjection of N-acetyl-L-Cys
significantly attenuated the expression levels of Srx protein and
mRNA in the livers of pyrazole-treated mice. (Fig. 2F–H).
Pyrazole elicits selective accumulation
of PrxIII–SO2 in the liver of Srx-deficient mice
We next examined the effect of pyrazole on the hyperox-
idation of 2-Cys Prxs in the liver of wild-type and Srx
knockout (Srx -/ - ) mice by immunoblot analysis with anti-
bodies that recognize a specific sequence surrounding the CP–
SO2H moiety (37). Given that the active site sequence is the
same for 2-Cys Prxs (PrxI to IV) and that the sizes of PrxI and
PrxII are identical, the sulfinic forms of PrxI and PrxII cannot
be differentiated by immunoblot analysis. However, the sizes
of PrxI/II, PrxIII, and PrxIV are sufficiently different for the
discrimination by such an analysis. A pyrazole injection in-
duced an approximately threefold increase in the amount of
sulfinic PrxIII (PrxIII–SO2) in the liver of wild-type mice (Fig.
3A, B). The intensity of the PrxIII–SO2 band was slightly
greater for the liver of Srx -/- mice than for that of Srx +/ +
mice before pyrazole treatment, and pyrazole induced an
approximately fourfold increase in the intensity of this band in
Srx-/- mice (Fig. 3A, B). The extent of PrxIII hyperoxidation
was evaluated further by two-dimensional (2D) polyacryla-
mide gel electrophoresis (PAGE) followed by immunoblot
analysis (Fig. 3C). Hyperoxidation of a Cys residue induces an
acidic (leftward) shift in the position of proteins on 2D gels.
The intensities of PrxIII spots suggest that 20% to 30% of PrxIII
was hyperoxidized in the liver of pyrazole-treated Srx -/-
mice. The amount of PrxI/II–SO2 in the liverwas not affected by
either a pyrazole injection or Srx ablation alone, but it was
slightly increased by pyrazole treatment in Srx-/- mice (Fig.
3A). Neither a pyrazole injection nor Srx ablation affected the
expression levels of PrxI to IV (Fig. 3A). The amounts of glu-
tathione peroxidase (Gpx), catalase, Zn- and Cu-dependent
superoxide dismutase (SOD), and Mn-dependent SOD were
also not affected by pyrazole treatment or Srx ablation (Fig. 3D).
Pyrazole increases CYP2E1 abundance
in mitochondria to a greater extent than in ER
and induces Srx translocation to both
mitochondria and the ER
Both ethanol and pyrazole increase the abundance of
CYP2E1 in the ER andmitochondria of rat liver (4, 29, 35). We
find, however, that pyrazole induced the hyperoxidation of
PrxIII but not that of PrxI and II in the liver. We, therefore,
investigated whether the abundance of CYP2E1 in hepatic
mitochondria might be increased to a greater extent than that
in microsomes in pyrazole-injected mice. Liver homogenates
prepared from pyrazole-treated mice were subjected to sub-
cellular fractionation, and the abundance of CYP2E1 in the
total homogenate, microsomal fraction, and mitochondrial
fraction was examined by immunoblot analysis. The fidelity
of the subcellular fractionationwas confirmed by immunoblot
analysis with antibodies to the 78-kDa glucose-regulated
protein (GRP78, an ER marker) and those to cytochrome c
FIG. 3. Effects of pyrazole on the abundance and hyper-
oxidation of 2-cysteine (Cys) peroxiredoxins (Prxs) in the
liver of Srx1/1 or Srx2/2mice. (A) Liver homogenates (20lg
of protein) prepared 18 h after an intraperitoneal injection of
Srx +/+ or Srx -/ - mice with saline (- ) or pyrazole (150mg/
kg) were subjected to an immunoblot analysis with anti-
bodies to Srx, to hyperoxidized 2-Cys Prxs (Prx–SO2), to PrxI
to IV, or to b-actin. A total lysate (5lg of protein) of NIH 3T3
cells that had been treated with 100lM H2O2 for 10min was
used as a positive control for hyperoxidized forms of PrxI/II
and III. Data are representative of three independent exper-
iments. (B) Densitometric analysis of PrxIII–SO2 abundance
in immunoblots similar to those in (A). Data are means – SD
and are expressed relative to the normalized value for saline-
injected Srx +/+ mice. *p < 0.05 versus pyrazole-injected
Srx +/+ mice. (C) Liver homogenates (250 lg of protein)
prepared from mice treated as in (A) were subjected to two-
dimensional polyacrylamide gel electrophoresis followed by
an immunoblot analysis with antibodies specific for Prx–SO2
and PrxIII. Ox and Re indicate spots corresponding to hy-
peroxidized and reduced forms, respectively, of PrxIII. (D)
Liver homogenates (250 lg of protein) prepared from mice
treated as in (A) were subjected to an immunoblot analysis
with antibodies to glutathione peroxidase (Gpx), to catalase
(Cat), to Zn- and Cu-dependent superoxide dismutase (Zn/
Cu-SOD), to Mn-dependent superoxide dismutase (Mn-
SOD), or to b-actin. Data are representative of three inde-
pendent experiments.
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oxidase IV (COXIV, a mitochondrial marker). Pyrazole
treatment induced 1.4- and 3.5-fold increases in the amount of
CYP2E1 in the microsomal and mitochondrial fractions, re-
spectively (Fig. 4A, B). A direct assay of CYP2E1 activity also
indicated that pyrazole treatment increased CYP2E1 activity
in the mitochondrial fraction to a greater extent than in the
microsomal fraction (Fig. 4C). In addition, pyrazole treatment
significantly increased lipid peroxidation in mitochondria but
not in microsomes (Fig. 4D).
Srx is a cytosolic protein, but it translocates to the mito-
chondria in response to oxidative stress (3, 25). We previously
showed that Srx also translocates to the cytosolic side of the
ER membrane as well as to mitochondria in the liver of
ethanol-fed mice (2). We, therefore, examined the effect of
pyrazole treatment on the subcellular distribution of Srx in the
liver. Srxwas detected in the cytosol but not in themicrosomal
ormitochondrial fractions of the liver of controlmice, whereas
it was present in all three fractions of the liver of pyrazole-
treated mice (Fig. 4E).
Pyrazole induces ER stress that results
in the accumulation of Ca2+ and ROS in mitochondria
The larger effect of pyrazole on CYP2E1 abundance in
mitochondria than in ER might account, in part, for the se-
lective hyperoxidation of PrxIII that is apparent in the liver of
pyrazole-treated mice. On the other hand, the relatively small
difference in the amount of CYP2E1 in liver mitochondria
versus that in microsomes might not be sufficient to account
for such selectivity.
Pyrazole was previously shown to induce ER stress, as
evidenced by an increase in the amount of GRP78, in mouse
hepatocytes (13). We also found that the level of GRP78 was
increased in the liver of pyrazole-treated mice (Supplemen-
tary Fig. S3A, B). ER stress results in phosphorylation of the a
subunit of eukaryotic initiation factor 2 (eIF2a) by double-
stranded RNA–activated protein kinase–like ER kinase
(PERK) (22). Increased phosphorylation of eIF2a was also
observed in the liver of pyrazole-treatedmice (Supplementary
Fig. S3A, B). In addition, pyrazole treatment increased the
hepatic abundance of mRNAs for ER stress-related proteins,
including those for GRP78, TRB3 (a mammalian ortholog
of Drosophila Tribbles), and ER degradation–enhancing a-
mannosidase–like protein (EDEM; Supplementary Fig. S3C).
The function of the ER is closely linked to that of mito-
chondria. These two organelles, thus, constitute a dynamic
network that underlies intracellular Ca2 + signaling. ER stress
often results in the increased loading of Ca2 + inmitochondria,
and a protracted increase in the amount of Ca2 + in the matrix
of mitochondria stimulates mitochondrial metabolism and
disrupts the electron transport chain, leading to the increased
production of ROS (9, 15, 22). We, therefore, investigated
whether pyrazole might increase the level of Ca2 + in the mi-
tochondria of HeLa (human cervical cancer) and Hepa1c1c7
(mouse hepatoma) cells with the use of the mitochondrion-
specific Ca2 + indicator Rhod-2, which becomes enriched in
mitochondria as a result of its positive charge. Treatment with
the Ca2 + ionophore A23187 resulted in a marked increase in
Rhod-2 fluorescence, indicative of mitochondrial Ca2 + accu-
mulation, in both HeLa and Hepa1c1c7 cells (Fig. 5A, B).
Treatment with pyrazole also induced mitochondrial Ca2 +
accumulation, albeit at a slower rate than that observed with
A23187 (Fig. 5A, B). We then measured the effect of pyrazole
on ROS production in the mitochondria with the use of Mi-
toSox Red, a mitochondrial-specific superoxide indicator. The
respiratory chain complex I inhibitor rotenone was used as a
positive control for superoxide generation. Pyrazole increased
mitochondrial ROS in HeLa or Hepa1c1c7 cells, and the effect
was blocked by ruthenium red, an inhibitor of mitochondrial
calcium transport (Fig. 5C, D). These results suggested that
pyrazole-induced ER stress might be responsible for the in-
crease in mitochondrial ROS. Indeed, pyrazole induced ER
stress, as indicated by the increased expression of GRP78 and
FIG. 4. Effects of pyrazole on the abundance or subcel-
lular localization of CYP2E1 and Srx. (A) Liver homoge-
nates prepared from mice 18 h after an intraperitoneal
injection of either saline (- ) or pyrazole (150mg/kg) were
fractionated into mitochondrial (Mito), microsomal (Mic),
and cytosolic (Cyt) fractions. The Mic and Mito fractions
(20 lg of protein) were subjected to an immunoblot analysis
with antibodies to CYP2E1, to GRP78, or to cytochrome c
oxidase IV (COXIV). Data are representative of three inde-
pendent experiments. (B) Densitometric analysis of relative
CYP2E1 abundance in immunoblots similar to those in (A).
Data are means – SD. *p< 0.05 versus corresponding values
for the control group. (C) CYP2E1 activity was measured in
the Mito and Mic fractions prepared as in (A). Data are
means – SD, n = 3. **p< 0.05 versus corresponding values for
the control group. (D) The Mic and Mito fractions (20 lg of
protein) were assayed for lipid peroxidation by measuring
MDA with the use of a thiobarbituric acid–reactive substance
(TBARS) assay kit (Cayman Chemical, Ann Arbor, MI). Data
are expressed as relative values to the control group and are
means – SD, n = 3. ***p< 0.05 versus corresponding values for
the control group. (E) Cyt, Mic, and Mito fractions (20lg
of protein) from the liver of mice treated as in (A) were
subjected to an immunoblot analysis with antibodies to Srx
as well as with those to the respective marker proteins b-
tubulin, GRP78, and COXIV.
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of phosphorylation of eIF2a in HeLa or Hepa1c1c7 cells
(Supplementary Fig. S4A–D). Pyrazole also increased protein
carbonylation in the mitochondria of the two cell lines (Sup-
plementary Fig. S4E, F).
Ablation of PrxIII or Srx exacerbates pyrazole-induced
oxidative liver injury
Though mitochondria contain peroxide-eliminating en-
zymes such as Gpx and Prx V,*90% of mitochondrial H2O2
was estimated to react with PrxIII (8). To elucidate the role of
PrxIII in the protection of the liver from pyrazole-induced
oxidative injury, we generated PrxIII knockout (PrxIII -/- )
mice (Supplementary Fig. S6) and examined the amount of
carbonylated (oxidized) proteins in the liver of pyrazole-
treated PrxIII +/ + and PrxIII -/- mice. Carbonylated proteins
were detected by derivatization of the carbonyl group with
2,4-dinitrophenylhydrazine (DNPH) followed by immuno-
blot analysis with antibodies to DNPH (Fig. 6A). Given that
no protein bands were detected when DNPH was omitted
from the derivatization mixture (Supplementary Fig. S7), the
multiple bands apparent in each lane in Figure 6A likely
represent carbonylated proteins. Pyrazole increased the level
of protein carbonylation in the liver of both PrxIII +/+ and
PrxIII -/ - mice, but a quantitative assay revealed that the
extent of protein carbonylation in pyrazole-treated PrxIII -/-
mice was 3.3 times that in pyrazole-treated PrxIII +/ + mice
(Fig. 6B). We next examined lipid peroxidation as revealed by
detection of the markers 4-hydroxynonenal (4-HNE) and
malondialdehyde (MDA). An immunohistochemical analysis
showed that ablation of PrxIII markedly enhanced the pyr-
azole-induced formation of 4-HNE adducts in the cen-
trilobular region of the liver of mice(Fig. 6C). Furthermore, the
amount of MDA in the liver of pyrazole-treated PrxIII -/ -
mice was 2.4 times that in pyrazole-treated PrxIII +/ + mice
(Fig. 6D). Pyrazole also increased the frequency of apoptotic
cell death in the liver of PrxIII -/- mice to a markedly greater
extent than in that of PrxIII +/ + mice (Fig. 6E, F).
Finally, we also investigated the role of Srx in protection of
the liver from pyrazole-induced oxidative injury in the use of
Srx -/- mice (Supplementary Fig. S5). Pyrazole induced
protein carbonylation, 4-HNE adduct formation, and MDA
production in the liver of Srx -/- mice to a greater extent than
in that of Srx +/ + mice (Fig. 7). The effects of Srx ablation
appeared to be less pronounced than those of PrxIII ablation,
however, as revealed by the 1.6- and 1.7-fold increases in
FIG. 5. Effects of pyrazole on the
level of Ca21 and reactive oxygen
species (ROS) production in mito-
chondria of HeLa and Hepa1c1c7
cells. (A, B)HeLa (A) or Hepa1c1c7 (B)
cells were exposed to A23187 (10 lM),
DMSO, pyrazole (Pyr, 25lM), or PBS.
The amount of Mito Ca2 + was moni-
tored as described under Supplemen-
tary Materials and Methods. Data are
expressed as relative fluorescence units
(RFU) and are from an experiment that
was performed for a total of four times
with similar results. (C, D) HeLa (C) or
Hepa1c1c7 (D) cells were treated with
pyrazole (100 lM), pyrazole (100lM)
plus ruthenium red (RR, 5lM), or ro-
tenone (ROT, 50lM) in the presence of
MitoSox Red dye (5lM) for 30min at
37C and rinsed with PBS. The fluo-
rescence intensity was measured by
flow cytometry. The black line indi-
cates the control group, and the red
line indicates each treatment group.
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pyrazole-induced protein carbonylation (Fig. 7A, B) and
MDA formation (Fig. 7D), respectively, compared with the
corresponding values of 3.3- and 2.4-fold for PrxIII ablation.
Discussion
Pyrazole increases the abundance of CYP2E1. We have
now shown that pyrazole also increases the levels of Srx
protein and mRNA in the mouse liver. The availability of
Nrf2 -/ - mice allowed us to show that pyrazole-induced Srx
expression is largely dependent on Nrf2 function. Our results,
thus, suggest that pyrazole stimulates the intracellular pro-
duction of ROS by up-regulating CYP2E1 abundance, and
that the generated ROS trigger the release of Nrf2 from Keap1
and its translocation to the nucleus, where it binds to the ARE
in the promoter region of genes for various antioxidant
FIG. 6. Effects of PrxIII ablation on oxidative liver damage induced by pyrazole. (A) Liver homogenates (20lg of protein)
prepared from PrxIII +/+ or PrxIII -/- mice 18 h after an intraperitoneal injection with saline (- ) or pyrazole (150mg/kg)
were subjected to an immunoblot analysis of carbonylated proteins with the use of an Oxyblot Protein Oxidation Detection
Kit (Chemicon, Temecula, CA). Molecular size markers are indicated in kilodaltons. Data are representative of three inde-
pendent experiments. (B) Liver homogenates (20lg of protein) from the mice treated as in (A) were subjected to an enzyme-
linked immunosorbent assay for carbonylated proteins with the use of an OxyELISA Kit (Chemicon, Temecula, CA). Data are
expressed as nanomoles of carbonyl group per milligram of protein and are means – SD, n = 3. **p< 0.03 versus pyrazole-
treated PrxIII +/ + mice. (C) Liver sections from the mice treated as in (A) were subjected to an immunohistochemical analysis
with or without antibodies (Ab- ) to 4-hydroxynonenal (4-HNE) with the use of an ABC staining kit (Vector Laboratories,
Mississauga, Ontario, Canada). CV, central vein. Original magnification, 100 · . (D) Liver homogenates (20 lg of protein) from
mice treated as in (A)were assayed for MDA with the use of a TBARS assay kit (Cayman Chemical, Ann Arbor, MI). Data are
expressed as micromoles per milligram of protein and are means – SD, n = 3. **p < 0.03 versus pyrazole-treated PrxIII +/ +
mice. (E) Liver sections from mice treated as in (A) were subjected to TUNEL analysis, which uses an In Situ Cell Death
Detection Kit, TMR Red (Roche, Indianapolis, IN). The fluorescence signals were detected with a confocal microscope (LSM
510, Zeiss). Arrows indicate apoptotic cells. (F) The frequency of apoptotic cells in sections similar to those in (E) was
quantified by counting the number of TUNEL-positive cells in 10 random microscopic fields and presenting them as the
percentage of cells that were TUNEL positive. *p < 0.05 versus pyrazole-treated PrxIII +/ + mice. (To see this illustration in
color the reader is referred to the web version of this article at www.liebertpub.com/ars.)
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proteins, including Srx, thereby activating their transcription
(Fig. 8). Although pyrazole-treated mice usually do not overt
liver toxicity, pyrazole induces pronounced oxidative liver
damage in Nrf2 -/- mice (21). Such damage was attributed to
the failure of these mice to induce compensatory increases in
the abundance of Nrf2-regulated antioxidant enzymes such as
c-glutamylcysteine synthetase, heme oxygenase–1, and glu-
tathione S-transferase (21). Our findings now suggest that Srx
is also a key target of Nrf2 that is necessary to protect the liver
from pyrazole-induced injury. Srx is a cytosolic protein that is
able to translocate to sites where hyperoxidized (inactivated)
2-Cys Prxs are located, thereby engaging in reactivation of the
inactivated enzymes under oxidative conditions (25). We
have now shown that pyrazole treatment induced the trans-
location of Srx molecules to mitochondria and microsomes in
the mouse liver (Fig. 8).
Among the four members of the 2-Cys Prx subgroup, only
PrxIII was found to be hyperoxidized in the liver of pyrazole-
treated wild-type mice, suggesting that the rate of hyperox-
idation of PrxIII in mitochondria exceeded the capacity of Srx
molecules which translocated to these organelles. In contrast,
PrxI, but not PrxIII, was previously found to be hyperoxidized
in the liver of ethanol-fed mice (2). Given that 2-Cys Prxs
undergo hyperoxidation only when engaged in the catalytic
cycle, the extent of PrxIII hyperoxidation is determined by the
amount of ROS produced and the capacity of Srx to reverse
the hyperoxidation. One of themajor ROS sources responsible
for PrxIII hyperoxidation in the liver of pyrazole-treated mice
is CYP2E1, which, alongwith PrxIII, is present in thematrix of
mitochondria (5, 7). A small proportion of PrxI molecules in
microsomes was found to be hyperoxidized in the liver of
pyrazole-treated Srx -/- mice, consistent with the notion that
PrxI–SO2 was not detected in the liver of pyrazole-treated
Srx +/+ mice, because the capacity of Srx located at the surface
of the ER is sufficient to counteract the unavoidable hyper-
oxidation of PrxI. Despite the fact that both PrxI and PrxII
exist in the cytosol and that PrxII is more prone to hyperox-
idation than is PrxI, PrxII–SO2 was not detected in the liver of
pyrazole-treated wild-type or Srx -/- mice, suggesting that
PrxII was not engaged in ROS elimination rather than that the
capacity of Srx in the cytosol was sufficient to counteract its
hyperoxidation.
CYP2E1 is an abundant protein in the liver that is pre-
dominantly located in microsomes. However, a substantial
amount of CYP2E1 is also present in other cellular compart-
ments, including mitochondria (4, 23, 29). The abundance of
CYP2E1 in mitochondria and microsomes was increased 3.5-
and 1.4-fold, respectively, in pyrazole-treated mice. It has
been shown that mitochondrial CYP2E1 is more potent in
generating ROS than the ER CYP2E1 (5, 31), probably because
FIG. 7. Effects of Srx ablation on oxi-
dative liver damage induced by pyr-
azole. (A) Liver homogenates (20lg of
protein) prepared from Srx+/+ or Srx-/-
mice 18h after an intraperitoneal injection
with saline (- ) or pyrazole (150mg/kg)
were subjected to an immunoblot analy-
sis of carbonylated proteins with the use
of an Oxyblot Protein Oxidation Detec-
tion Kit (Chemicon, Temecula, CA). Data
are representative of three independent
experiments. (B) Liver homogenates
(20lg of protein) from mice treated as in
(A) were subjected to an enzyme-linked
immunosorbent assay for carbonylated
proteins with the use of an OxyELISA Kit
(Chemicon, Temecula, CA). Data are ex-
pressed as nanomoles of the carbonyl
group per milligram of protein and are
means–SD, n=3. **p<0.01 versus pyr-
azole-treated Srx+/+ mice. (C) Liver
sections frommice treated as in (A)were
subjected to an immunohistochemical
analysis with or without antibodies
(Ab- ) to 4-HNEwith the use of an ABC
staining kit (Vector Laboratories, Mis-
sissauga, Ontario, Canada). CV, central
vein. Original magnification, 100· . (D)
Liver homogenates (20lgofprotein) from
mice treated as in (A) were assayed for
MDA with the use of an OxyELISA Kit
(Chemicon, Temecula, CA). Data are ex-
pressed as micromoles per milligram of
protein and are means–SD, n=3.
**p<0.01 versus pyrazole-treated Srx+/+
mice. (To see this illustration in color the
reader is referred to the web version of
this article at www.liebertpub.com/ars.)
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CYP2E1 is more loosely coupled to its mitochondrial electron
donor ferrodoxin compared with its ER electron donor cyto-
chrome P450 reductase.
Our observation that chlormethiazole inhibited the
pyrazole-induced up-regulation of Srx by only *40%
whereas it inhibited that of CYP2E1 by *90% suggested
the existence of a pyrazole-induced ROS source other than
CYP2E1. Pyrazole is also thought to increase ROS levels in
peroxisomes, given that the peroxisomal enzymes catalase
and inducible nitric oxide synthase are inhibited and up-
regulated, respectively, by pyrazole (21, 33). It is not likely,
however, that the ROS produced in peroxisomes are able to
travel to mitochondria, thereby promoting PrxIII hyper-
oxidation. Another CYP2E1-independent ROS source is
mitochondria themselves, which are physically and func-
tionally linked to the ER. These two organelles constitute a
dynamic network that contributes to intracellular Ca2 +
signaling. Pyrazole induces ER stress, which is known to
result in Ca2 + leakage from the lumen of the ER (9, 15, 22).
The Ca2 + released from the ER is taken up by mitochondria
and becomes concentrated in the mitochondrial matrix.
Indeed, with the use of the indicator Rhod-2, we have now
shown that pyrazole induced Ca2 + accumulation in the
mitochondria of HeLa and Hepa1c1c7 cells. Increased Ca2 +
concentration stimulates mitochondrial ROS production
through multiple mechanisms, including the activation of
metabolism and the disruption of electron transport (9, 15,
22). Mitochondrial ROS can further increase Ca2 + release
from the ER by sensitizing ER Ca2 + -release channels (9, 15,
22). The ER stress initiated by pyrazole, thus, triggers a
positive feedback loop that results in the accumulation of
Ca2 + and ROS in mitochondria (Fig. 8). The preferential
hyperoxidationof PrxIII in pyrazole-treated mice is, there-
fore, attributable to the cumulative effect of the preferential
induction of CYP2E1 and ER stress-derived ROS produc-
tion in mitochondria.
The elimination of mitochondrial ROS by PrxIII is accom-
panied by PrxIII hyperoxidation, and the accumulation of
inactive PrxIII results in the buildup of ROS in mitochondria.
The overflow of excess ROS into the cytosol triggers Nrf2
activation (Fig. 8) and inflicts oxidative damage. Oxidative
damage to the liver caused by pyrazole-induced ROS pro-
duction can be assessed by the measurement of carbonylated
proteins, 4-HNE adducts, and MDA (10, 14). The antioxidant
role of PrxIII was, thus, evident from our findings that pyr-
azole-induced protein carbonylation as well as the formation
of 4-HNE adducts and MDA in the liver were markedly in-
creased in PrxIII-/- mice compared with wild-type mice.
Increased mitochondrial production of ROS resulting from
PrxIII ablationwas also associatedwith apoptotic cell death in
the liver of pyrazole-treated PrxIII -/ - mice. Ablation of Srx
also potentiated pyrazole-induced oxidative damage in the
liver, albeit to a lesser extent than did PrxIII ablation, indica-
tive of the key role of Srx as the guardian of 2-Cys Prxs.
Materials and Methods
Materials
Antibodies specific for PrxI to VI and for hyperoxidized 2-
Cys Prxs (Prx–SO2) were obtained from Young In Frontier
(Seoul, Korea). Polyclonal antibodies to Srx were previously
described (37), and a mouse monoclonal antibody to Srx was
generated in house. Other antibodies were obtained from the
following sources: b-actin (Sigma Aldrich, St. Louis, MO),
GRP78 (Stressgen, Ann Arbor, MI), CYP2E1 (Abcam, Cam-
bridge, UK), COXIV (Cell Signaling, Beverly, MA), 4-HNE
( JaICA, Fukuroi, Japan), p-eIF2a, eIF2a (Cell Signaling, Dan-
vers, MA), and b-tubulin (Santa Cruz Biotechnology, Santa
Cruz, CA). Pyrazole, chlormethiazole, and rotenone were
obtained from Sigma Aldrich (St. Louis, MO). A23187 was
obtained from Invitrogen (Carlsbad, CA). Ruthenium redwas
obtained from Calbiochem (San Diego, CA).
Animals and treatments
All animals were housed with a 12-h-light, 12-h-dark cycle
in a temperature-controlled environment. Male C57BL/6
mice and breeding pairs of Nrf2 -/- mice were obtained from
The Jackson Laboratory (Bar Harbor, ME) and RIKEN BioR-
esource Center (Tsukuba, Japan), respectively. Overall, 8- to
10-week-old male mice were intraperitoneally injected with
pyrazole (150mg/kg) or saline, and, 18 h later, they were
anesthetized by an intraperitoneal injection of pentobarbital
(50mg/kg), and the liver was perfused with phosphate-
buffered saline, excised, and cut into fragments. All proce-
dures were approved by the Animal Care and Use Committee
of the Ewha Womans University.
RT-PCR analysis
Total RNAwas isolated from liver tissue with the use of the
Trizol reagent (Invitrogen, Carlsbad, CA). Portions (2lg) of
the RNAwere subjected to RT with random hexamer primers
and with the use of an ABI cDNA synthesis kit (PE Biosys-
tems, Foster City, CA). For verification of the genotype ofNrf2
knockout mice, the resulting cDNA (1lg) was subjected to
FIG. 8. Model for pyrazole-induced ROS production,
PrxIII hyperoxidation, and Srx expression in mouse liver.
See text for details.
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PCR analysis with the primers specific for Nrf2 and b-actin, as
previously described (3). Real-time (quantitative) PCR anal-
ysis was performed with the use of 18S rRNA as an internal
control. The primer sequences for Srx and PrxI to VI were
previously described (11), aswere those for TRB3, GRP78, and
EDEM (16).
Subcellular fractionation and immunoblot analysis
Liver homogenates and subcellular fractions thereof were
prepared as previously described (2). 2D gel electrophoresis
and immunoblot analysis were also previously described
(2). The abundance of target proteins was quantitated by a
densitometric analysis of immunoblots with NIH ImageJ
software.
CYP2E1 activity assay
The CYP2E1 activity in the mitochondrial or microsomal
fraction was determined as described (29).
Statistical analysis
Unless indicated otherwise, quantitative data were pre-
sented asmeans – standard deviation andwere analyzedwith
the two-tailed Student’s t-test. A p-value of < 0.05 was con-
sidered statistically significant.
For additional details on Materials and Methods, please
refer the Supplementary Data.
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Abbreviations Used
ARE¼ antioxidant-responsive element
COXIV¼ cytochrome c oxidase IV
Cys¼ cysteine
DNPH¼ 2,4-dinitrophenylhydrazine
EDEM¼ER degradation–enhancing a-mannosidase–
like protein
eIF2¼ eukaryotic initiation factor 2
ER¼ endoplasmic reticulum
Gpx¼ glutathione peroxidase
GRP¼ glucose-regulated protein
4-HNE¼ 4-hydroxynonenal
MDA¼malondialdehyde
Nrf2¼nuclear factor erythroid 2–related factor 2
PCR¼polymerase chain reaction
Prx¼peroxiredoxin
ROS¼ reactive oxygen species
RT¼ reverse transcription
Srx¼ sulfiredoxin
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